Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE)
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting of risk minimisation programme evaluations. |
| Full bibliographic reference | Smith MY, Morrato EH, Mora N, Nguyen V, Pinnock H, Winterstein AG. The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE). Drug Saf. 2024. |
| Language | English |
| PubMed ID | 38478350 |
| Relevant URLs (full-text if available) |
The checklist is available in Supplemental File 3 (PDF). |
| Explanation and elaboration papers | The E&E document is available in Supplemental File 4 (PDF). |
| Relevant more generic / specialised reporting guidelines (i.e. main generic guideline or extension to a generic guideline) |
|
| Reporting guideline acronym | RIMES-SE |
| Study design | Mixed methods studies, Observational studies |
| Clinical area | Pharmaceutical medicine, Public health |
| Applies to the whole report or to individual sections of the report? | Whole report |
| Record last updated on | June 12, 2024 |